ViewRay (VRAY) Misses Q1 EPS by 12c, Slight Miss on Revenues; Offers FY19 Revenue Outlook

ViewRay (NASDAQ: VRAY) reported Q1 EPS of ($0.34), $0.12 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $20.3 million versus the consensus estimate of $20.4 million.

"Our first quarter results are a solid start to the year and reflect progress on our commercial, innovation, and clinical pipelines," said Scott Drake, President and CEO. "We are well-positioned to execute in 2019 and are focused on becoming the standard of care in radiation oncology."

GUIDANCE:

ViewRay sees FY2019 revenue of $111-124 million, versus the consensus of $117 million.

For earnings history and earnings-related data on ViewRay (VRAY) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Seritage Growth Properties (SRG) Reports Q2 Loss of $0.13
• Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c